Funding will accelerate US scale-up of EOlife®, a real-time ventilation feedback device designed to improve cardiac arrest resuscitation survival and neurological outcomes. Validation of EU and US clinical studies involving 1,500+ real-world cardiac arrest patients is key to global expansion and the ambition to
Read More
